You are here:
NICE
NICE Guidance
Conditions and diseases
Mental health, behavioural and neurodevelopmental conditions
Bipolar disorder
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder
Technology appraisal guidance
Reference number:
TA292
Published:
24 July 2013
Guidance
Tools and resources
Information for the public
Evidence
History
Download guidance (PDF)
Overview
1 Guidance
2 The technology
3 The manufacturer's submission
4 Consideration of the evidence
5 Implementation
6 Related NICE guidance
7 Review of guidance
8 Appraisal Committee members, guideline representatives and NICE project team
9 Sources of evidence considered by the Committee
Changes after publication
About this guidance
Changes after p
ublication
January 2014:
minor maintenance
Next page
About this guidance
Previous page
9 Sources of evidence considered by the Committee